Funding

Turn ideas into impact

Viewing all 836 opportunities
Filter Options
836 results :
Filter List
Close
Update Filters
2
Type
Amount
Source
Eligibility
Status
View 836 Results
Clear All Filters

Due: September 25, 2026

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

Type

Grant

Source

Federal

Opp Number

PAR-23-284

Due: September 25, 2026

Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-24-167

Due: September 25, 2026

Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-25-247

Due: September 25, 2026

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)

US $350,000

Type

Grant

Source

Federal

Opp Number

PAR-24-259

Due: September 25, 2026

Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-24-071

Due: September 25, 2026

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)

Type

Grant

Source

Federal

Opp Number

PAR-23-228

Due: September 26, 2026

Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research

US $400,000

Type

Grant

Source

Federal

Due: September 26, 2026

Alcohol Research-Related Resource Award (

US $500,000

Type

Grant

Source

Federal

Due: September 28, 2026

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)

Type

Grant

Source

Federal

Opp Number

PAR-25-156

Submit your funding opportunity.

Do you have a grant, incentive, funding competition, or other funding source to share?

Next up:

Facilities